Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
BMC Cancer. 2023 Mar 28;23(1):278. doi: 10.1186/s12885-023-10759-9.
The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into account the perspectives of oncological healthcare providers (HCPs) in addition to those of patients. The aim of this study is to gain an in-depth understanding of HCPs' perspectives on appropriate melanoma SSC.
Four online focus groups were conducted with mixed samples of oncological HCPs (dermatologists, surgeons, oncologists, oncological nurse practitioners, support counsellors and general practitioners) (total n = 23). A topic guide was used to structure the discussions, focusing on perspectives on both SSC and survivorship care plans (SCPs). All focus groups were recorded, transcribed verbatim, and subjected to an elaborate thematic content analysis.
Regarding SSC, HCPs considered the current offer minimal and stressed the need for broader personalised SSC from diagnosis onwards. Although hardly anyone was familiar with SCPs, they perceived various potential benefits of SCPs, such as an increase in the patients' self-management and providing HCPs with an up-to-date overview of the patient's situation. Perceived preconditions for successful implementation included adequate personalisation, integration in the electronic health record and ensuring adequate funding to activate and provide timely updates.
According to HCPs there is considerable room for improvement in terms of melanoma SSC. SCPs can assist in offering personalised and broader i.e., including psychosocial SSC. Aside from personalisation, efforts should be focused on SCPs' integration in clinical practice, and their long-term maintenance.
越来越多的黑色素瘤幸存者报告了在生存护理（SSC）方面存在多种未满足的需求。为了优化黑色素瘤 SSC，除了患者的观点外，还必须考虑肿瘤医疗保健提供者（HCPs）的观点。本研究的目的是深入了解 HCPs 对适当的黑色素瘤 SSC 的看法。
对混合样本的肿瘤学 HCPs（皮肤科医生、外科医生、肿瘤学家、肿瘤学护士从业者、支持顾问和全科医生）（共 23 名）进行了四次在线焦点小组讨论。使用主题指南来组织讨论，重点关注 SSC 和生存护理计划（SCP）的观点。所有焦点小组都进行了录音、逐字记录，并进行了精心的主题内容分析。
关于 SSC，HCPs 认为目前的服务水平很低，强调从诊断开始就需要更广泛的个性化 SSC。尽管几乎没有人熟悉 SCPs，但他们认为 SCPs 具有多种潜在的好处，例如增加患者的自我管理能力，并为 HCPs 提供患者情况的最新概述。成功实施的预期前提包括充分的个性化、整合到电子健康记录中以及确保有足够的资金来激活并及时更新。
根据 HCPs 的观点，在黑色素瘤 SSC 方面有很大的改进空间。SCPs 可以帮助提供个性化和更广泛的，即包括心理社会 SSC。除了个性化，还应集中精力将 SCPs 整合到临床实践中，并长期维护。
